Aurora Cannabis Inc.

TSX:ACB.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$6.31 +0.48%

+$0.02 today

Market cap
$414.85M
Beta
1.34
P/E (TTM)
-3.2
EPS (TTM)
-$1.31
52W Low $3.77High $9.33

Volume 0.32M

Average 0.42M

ACB.TO Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Aurora Cannabis Inc.TSX: ACB.TO

Gross Margin · Q4 FY2026 · quarter ended Mar 2026

Gross margin widens to 47.7%

Gross margin was 47.7% in Q4 FY2026, up 23.5 pp from a year earlier. On a trailing-twelve-month basis it was 31.5%, down 23.2 pp year over year. Over 3 fiscal years it widened by 32.8 pp.

Context

  • Gross margin widened in 2 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
47.7%+41.8 pp QoQ
Last fiscal yearMar 2026
5.2%-49.4 pp YoY
LTMMar 2026
31.5%-23.2 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+23.5 pp——
1 year-49.4 pp——
3 years+32.8 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2026
5.2%
Year-over-year change
-49.4pp

Gross Margin vs competitors

How ACB.TO compares with its peers on the latest reported figures

  • ACB.TO's LTM Mar 2026 gross margin of 31.5% is the 5th highest of the 8 companies compared; the peer median is 47.5%.
  • Its year-over-year change of -23.2 pp is the 6th highest of 8, against a peer median of -5.8 pp.
  • Over three fiscal years its change of +32.8 pp compares with a peer median of -1.2 pp.
ACB.TO Competitors Peer median
Gross Margin for ACB.TO and competitors
Company Period LTM level YoY 3-year change
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 202692.2% +1.9 pp-2.8 pp
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 202674.5% +2.6 pp-14.9 pp
TSND.TOTerrAscend Corp.LTM Mar 202650.9% -0.7 pp+0.4 pp
XLY.TOAuxly Cannabis Group Inc.LTM Mar 202647.5% -5.8 pp+39.8 pp
ACB.TOAurora Cannabis Inc.LTM Mar 202631.5% -23.2 pp+32.8 pp
WEED.TOCanopy Growth CorporationLTM Mar 202623.6% -5.9 pp+54.0 pp
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026-3.1% -35.8 pp—
EDT.TOSpectral Medical Inc.LTM Mar 2026-79.2% -128.4 pp-270.1 pp
Peer median (excluding ACB.TO) 47.5%-5.8 pp-1.2 pp

Competitors are the stored peer set for ACB.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2022
Jun 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue221.34M233.29M270.28M343.29M320.59M
Cost of Revenue200.11M297.65M138.82M155.69M303.89M
Gross Profit21.23M(64.36M)131.46M187.61M16.7M
Gross Margin9.6%-27.6%48.6%54.6%5.2%
Research & Development10.39M6.56M3.57M3.68M4.02M
Selling, General & Admin188.99M183.4M156.88M166.47M173.5M
Operating Expenses252.67M189.96M177.91M182.66M179.5M
Depreciation & Amortization93.66M43.57M33.07M22.55M14.19M
EBITDA(1.55B)(210.74M)(12.34M)51.35M(162.79M)
EBITDA Margin-702.4%-90.3%-4.6%15.0%-50.8%
Operating Income(231.45M)(254.32M)(46.45M)4.95M(162.79M)
Operating Margin-104.6%-109.0%-17.2%1.4%-50.8%
Interest Income4.51M19M12.81M11.51M5.85M
Interest Expense71.81M39.46M14.19M8.42M1.81M
Other Income / Expenses(1.49B)(41.1M)(13.15M)15.43M106.27M
Income Before Tax(1.72B)(295.42M)(59.6M)20.38M(56.52M)
Pre-Tax Margin-777.1%-126.6%-22.1%5.9%-17.6%
Income Tax Expense(2.14M)(20.32M)(554K)4.62M2.1M
Net Income(1.72B)(265.33M)(69.33M)1.59M(121.76M)
Net Margin-776.0%-113.7%-25.6%0.5%-38.0%
EPS (Basic)(79.92)(8.17)(1.28)0.03(2.15)
EPS (Diluted)(79.92)(8.17)(1.28)0.03(2.15)
Weighted Avg Shares21.49M32.27M51.26M54.88M56.71M
Weighted Avg Shares (Diluted)21.49M32.27M51.26M55.75M56.71M

Aurora Cannabis Inc.

TSX:ACB.TO

Intrinsic Alpha fair value

Locked

Current Price

$6.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.